For Immediate Release

Chicago, IL - May 14, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cypress Bioscience, Inc. (CYPB), Forest Laboratories, Inc. (FRX), Allied Irish Banks, p.l.c. (AIB), Baxter International (BAX) and Pfizer (PFE).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Wednesday's Analyst Blog:

Cypress Bio Banks on Savella

Cypress Bioscience, Inc. (CYPB) reported financial results for the first quarter 2009 on May 11, 2009. Total revenues for the quarter were $7.9 million, and consisted primarily of collaborative payments from Savella development partner, Forest Laboratories,

...

We highlight Baxter International, Inc. (BAX) and Pfizer, Inc. (PFE).Not long after reporting a decent first quarter, Baxter International (BAX) has made headlines once again for its heparin product.A renewed heparin-related scare began over the weekend, with two deaths announced and a third patient suffered complications. The common link between all three patients is the administration of heparin. Initial reports indicate that the pharmaceutical ingredients were sourced in North America, likely from Pfizer (PFE). The contaminant from the Chinese factory during the 2008 scare (over-sulfated chondroitin sulfate) was not found in the recently tested samples.Additionally, the mode of drug delivery differed. The heparin currently under investigation was delivered in pre-mixed, intravenous bags, whereas last year's tainted heparin was found in vials and drug-coated devices.For the quarter, net sales (excluding FX) increased 6% y/y. Higher margins on an adjusted ...

Mylan, Inc.'s (...